methylparaben has been researched along with Neuroleptic Malignant Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babini, E; Cavagna, D; Prestipino, G; Treves, S; Zorzato, F | 1 |
1 other study(ies) available for methylparaben and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel.
Topics: Animals; Antipsychotic Agents; Calcium; Dose-Response Relationship, Drug; Food Preservatives; Haloperidol; In Vitro Techniques; Neuroleptic Malignant Syndrome; Parabens; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 2000 |